At A Glance
- Ipamorelin is a short peptide studied for prompting growth-hormone release through the ghrelin receptor. Its development focused on a more selective response than some earlier GHRPs.
- Studies reported growth-hormone release with comparatively limited ACTH and cortisol effects.
- A randomized study explored recovery of bowel function after surgery.
What Is IPAMORELIN?
Ipamorelin is a short peptide studied for prompting growth-hormone release through the ghrelin receptor. Its development focused on a more selective response than some earlier GHRPs.
The idea was to stimulate growth hormone with less accompanying ACTH and cortisol activity. Early pharmacology work explored that balance, which is why selectivity is a recurring theme in ipamorelin discussions.
Why Is Selectivity Interesting?
A hormone signal rarely exists in isolation. Scientists want to know both what changes and what else changes alongside it. Comparing several hormone measurements helps describe how ipamorelin differs from other compounds using the same receptor.
How Does It Fit Beside CJC-1295 Or Sermorelin?
Ipamorelin uses the ghrelin receptor; the others use the GHRH route. Both routes can influence pituitary growth-hormone release. Ipamorelin also entered postoperative bowel-recovery research, but that programme did not establish an approved treatment.
A Closer Look At IPAMORELIN
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Early pharmacology | Selective hormone release | Studies reported growth-hormone release with comparatively limited ACTH and cortisol effects. | Selectivity is relative to the comparator and study conditions. |
| Clinical programme | Postoperative ileus | A randomized study explored recovery of bowel function after surgery. | The programme did not establish an approved treatment; it is a separate question from GH-release activity. |
Common Questions About IPAMORELIN
What is IPAMORELIN?+
Ipamorelin is a short peptide studied for prompting growth-hormone release through the ghrelin receptor. Its development focused on a more selective response than some earlier GHRPs.
Why is selectivity interesting?+
A hormone signal rarely exists in isolation. Scientists want to know both what changes and what else changes alongside it. Comparing several hormone measurements helps describe how ipamorelin differs from other compounds using the same receptor.
How does it fit beside CJC-1295 or sermorelin?+
Ipamorelin uses the ghrelin receptor; the others use the GHRH route. Both routes can influence pituitary growth-hormone release. Ipamorelin also entered postoperative bowel-recovery research, but that programme did not establish an approved treatment.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- Ipamorelin, the first selective growth hormone secretagoguePeer-reviewed publication · 1998
Early studies described dose-related GH release with comparatively limited ACTH/cortisol effects. These were pharmacology studies, not demonstrations of long-term body-composition or recovery outcomes.
- Randomized postoperative-ileus trial of ipamorelinPeer-reviewed publication · 2015
A randomized postoperative-ileus study did not lead to an approved treatment and development was discontinued. Negative development outcomes belong in a complete evidence summary.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For IPAMORELIN context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Explore IPAMORELIN
Review available strengths, pricing, stock status, and product documentation.